Bisphosphonate utilization across the spectrum of eGFR
ConclusionIn the two healthcare systems, approximately half of the people diagnosed with osteoporosis received BSP. Practices of prescription in relation to eGFR varied, but those with lower eGFR were less likely to receive BSP.
Source: Archives of Orthopaedic and Trauma Surgery - Category: Orthopaedics Source Type: research
More News: Chronic Kidney Disease | Orthopaedics | Osteoporosis | Study | Sweden Health | Toxicology | Urology & Nephrology | Women